AllAfrica.com/Guardian examine efforts to prevent and treat cervical cancer among women in Kenya, where an estimated 3,400 women die of the disease each year and only five percent receive screening. “Kenya’s national reproductive health strategic plan has addressed cervical cancer largely through the roll-out of a low-cost screening tool known as VIA (visual inspection of the cervix using ascetic acid),” but experts agree that more widespread use of cervical cancer vaccines and public education campaigns about the disease would be more effective at preventing and catching cases earlier, the news service reports. “Once the public owns this problem and pushes for it, … then the government would be forced to implement [a vaccine] strategy in full,” Lucy Muchiri, a pathologist specializing in cervical cancer at Kenyatta National Hospital and the University of Nairobi, said, the news service notes (Njoroge, 6/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.